Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Porträttfoto

Jonas Helgertz

Vicerektor forskning, Docent

Porträttfoto

Comorbidities in women with polycystic ovary syndrome : a sibling study

Författare

  • Beata Vivien Boldis
  • Ilona Grünberger
  • Agneta Cederström
  • Jonas Björk
  • Anton Nilsson
  • Jonas Helgertz

Summary, in English

BACKGROUND: Polycystic ovary syndrome (PCOS) has previously been associated with several comorbidities that may have shared genetic, epigenetic, developmental or environmental origins. PCOS may be influenced by prenatal androgen excess, poor intrauterine or childhood environmental factors, childhood obesity and learned health risk behaviors. We analyzed the association between PCOS and several relevant comorbidities while adjusting for early-life biological and socioeconomic conditions, also investigating the extent to which the association is affected by familial risk factors. METHODS: This total-population register-based cohort study included 333,999 full sisters, born between 1962 and 1980. PCOS and comorbidity diagnoses were measured at age 17-45 years through national hospital register data from 1997 to 2011, and complemented with information on the study subjects´ early-life and social characteristics. In the main analysis, sister fixed effects (FE) models were used to control for all time-invariant factors that are shared among sisters, thereby testing whether the association between PCOS and examined comorbidities is influenced by unobserved familial environmental, social or genetic factors. RESULTS: Three thousand five hundred seventy women in the Sister sample were diagnosed with PCOS, of whom 14% had obesity, 8% had depression, 7% had anxiety and 4% experienced sleeping, sexual and eating disorders (SSE). Having PCOS increased the odds of obesity nearly 6-fold (adjusted OR (aOR): 5.9 [95% CI:5.4-6.5]). This association was attenuated in models accounting for unobserved characteristics shared between full sisters, but remained considerable in size (Sister FE: aOR: 4.5 [95% CI: 3.6-5.6]). For depression (Sister FE: aOR: 1.4 [95% CI: 1.2-1.8]) and anxiety (Sister FE: aOR: 1.5 [95% CI: 1.2-1.8), there was a small decrease in the aORs when controlling for factors shared between sisters. Being diagnosed with SSE disorders yielded a 2.4 aOR (95% CI:2.0-2.6) when controlling for a comprehensive set of individual-level confounders, which only decreased slightly when controlling for factors at the family level such as shared genes or parenting style. Accounting for differences between sisters in observed early-life circumstances influenced the estimated associations marginally. CONCLUSION: Having been diagnosed with PCOS is associated with a markedly increased risk of obesity and sleeping, sexual and eating disorders, also after accounting for factors shared between sisters and early-life conditions.

Avdelning/ar

  • LU profilområde: Naturbaserade framtidslösningar
  • EPI@LUND
  • Kirurgi och folkhälsa
  • eSSENCE: The e-Science Collaboration
  • Centrum för ekonomisk demografi
  • Avdelningen för arbets- och miljömedicin
  • EpiHealth: Epidemiology for Health
  • Ekonomisk demografi
  • Ekonomisk-historiska institutionen

Publiceringsår

2024-04-05

Språk

Engelska

Sidor

221-221

Publikation/Tidskrift/Serie

BMC Women's Health

Volym

24

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

BioMed Central (BMC)

Ämne

  • Obstetrics, Gynecology and Reproductive Medicine

Nyckelord

  • Comorbidity
  • Polycystic ovary syndrome
  • Sibling fixed effect

Status

Published

Forskningsgrupp

  • EPI@LUND
  • Surgery and public health

ISBN/ISSN/Övrigt

  • ISSN: 1472-6874